Search
SOLACI Congress
Interventionist Societies

Sociedad Peruana de Hemodinámica e Intervencionismo Endovascular (SOPHIE)

solaci
solaci
149
0

Sociedad Peruana de Hemodinámica e Intervencionismo Endovascular (SOPHIE)

Previous article
SOLACI at ACC / AHA / SCAI recommendation guides
Next article
Eventos clínicos tardíos en pacientes diabéticos tratados con stents farmacológicos liberadores de sirolimus o everolimus: un análisis del registro DESIRE
solaci
solaci

More articles by this author

Asociación Dominicana de Cardiólogos Intervencionistas (ASODCI)

solaci - 0
Asociación Dominicana de Cardiólogos Intervencionistas (ASODCI)

Sociedad Venezolana de Cardiología Intervencionista (SOVECI)

solaci - 0
Sociedad Venezolana de Cardiología Intervencionista (SOVECI)

Colegio Colombiano de Hemodinamia e Intervencionismo Cardiovascular (CCHICV)

solaci - 0
Colegio Colombiano de Hemodinamia e Intervencionismo Cardiovascular (CCHICV)

Sociedad de Cardiología Intervencionista de México (SOCIME)

solaci - 0
Sociedad de Cardiología Intervencionista de México (SOCIME)

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

Interventionist Societies

Asociación Dominicana de Cardiólogos Intervencionistas (ASODCI)

Asociación Dominicana de Cardiólogos Intervencionistas (ASODCI)
solaci -
SOLACI Sessionsspot_img

Recent Articles

TAVR in Small Annuli: What Valve Should We Use?

Dr. Carlos Fava - 0
One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Dr. Andrés Rodríguez - 0
Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Dr. Omar Tupayachi - 0
Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

TAVR in Small Annuli: What Valve Should We Use?

Dr. Carlos Fava - 0
One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Dr. Andrés Rodríguez - 0
Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Dr. Omar Tupayachi - 0
Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...

Institutional News

April 9 – How to Apply for the SOLACI Research Grant 2025? Virtual Zoom Event

solaci - 0
The Latin American Society of Interventional Cardiology invites you to a new virtual event hosted by the SOLACI Research Department, aimed at clarifying doubts,...

Watch our event on Evidence and Controversies of Renal Denervation in 2025

solaci - 0
You can now watch our event, held in collaboration with Medtronic, titled "Evidence and Controversies of Renal Denervation in 2025." The event featured international experts...

March 26 – SOLACI Webinar: Evidence and Controversies in Renal Denervation in 2025

solaci - 0
The Latin American Society of Interventional Cardiology invites you to a new virtual event supported by Medtronic. On this occasion, we will hold a 60-minute...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy